[1] |
Cabanillas ME, Mcfadden DG, Durante C. Thyroid cancer[J]. Lancet, 2016, 388(10061): 2783.
|
[2] |
林清英, 陈志辉. 甲状腺癌相关影响因素研究进展[J]. 中国地方病防治杂志, 2016, 12(3): 260-263.
|
[3] |
Hu J, Li C, Liu C, et al. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the clinical characteristics of PTC[J]. Cancer Biomarkers, 2017, 18(1): 87.
|
[4] |
Thompson LD. Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: a name change to noninvasive follicular thyroid neoplasm with papillary-like nuclear features would help prevent overtreatment[J]. Mod Pathol, 2016, 29(7): 698-707.
|
[5] |
Pacini F, Castagna MG, Cipri C, et al. Medullary thyroid carcinoma[J]. Clin Oncol, 2010, 22(6): 475-485.
|
[6] |
Zhao HD, Tang HL, Liu NN, et al. Targeting ubiquitin-specific protease 22 suppresses growth and metastasis of anaplastic thyroid carcinoma[J]. Oncotarget, 2016, 7(21): 31191-31203.
|
[7] |
林明政, 沈国栋, 沈干, 等. T细胞因子4在胃癌细胞增殖凋亡中的作用研究[J]. 安徽医科大学学报, 2016, 51(8): 1092-1096.
|
[8] |
肖丽容, 郑仕洁, 侯宸, 等. 小鼠视网膜体外电转化及Transwell体外培养的方法[J]. 眼科新进展, 2018, 38(7): 620-624.
|
[9] |
Boehm EM, Gildenberg MS, Washington MT. The many roles of PCNA in eukaryotic DNA replication[J]. Enzymes, 2016, 39(8): 231-254.
|
[10] |
陈红, 王晓辉, 易田. 卵巢癌中GnRH及其受体的表达与细胞增殖和分化的关系[J]. 中国妇幼保健, 2008, 23(20): 2865-2867.
|
[11] |
石小燕, 胡国清, 曹荣华. 细胞周期素D1和Ki67在鼻咽癌中的表达及意义[J]. 中华放射肿瘤学杂志, 2003, 12(4): 273-274.
|
[12] |
Lu W, Lu T, Wei X. Downregulation of DNMT3a expression increases miR-182-induced apoptosis of ovarian cancer through caspase-3 and caspase-9-mediated apoptosis and DNA damage response[J]. Oncol Rep, 2016, 36(6): 3597-3604.
|
[13] |
孙桂超, 邹翔, 季宇彬. 细胞凋亡线粒体途径机制的研究[C]// 2009医学前沿论坛暨全国肿瘤药理与化疗学术会议, 2009.
|
[14] |
洪甜, 李玲, 李文超, 等. 人Six1基因缺失突变体对上皮钙黏素(E-cadherin)启动子活性的影响[J]. 细胞与分子免疫学杂志, 2016, 32(2): 224-227.
|
[15] |
任本洪, 孙雪娇, 郝跃鹏, 等. Aurora蛋白激酶抑制剂VX-680对人肝癌细胞HepG2细胞间同质黏附力和迁移能力的影响[J].中国病理生理杂志, 2018, 34(5): 945-949.
|
[16] |
Gao M, Zhang X, Li D, et al. Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma[J]. Oncotarget, 2016, 7(51): 85502-85514.
|
[17] |
Lazarova D L, Bordonaro M. Vimentin, colon cancer progression and resistance to butyrate and other HDACis[J]. J Cell Mol Med, 2016, 20(6): 989-993.
|
[18] |
金波, 高亮, 李望, 等. LIM和SH3蛋白1蛋白在肾透明细胞癌组织中的表达及其对肾透明细胞癌786-O细胞侵袭和迁移能力的影响[J]. 中华肿瘤杂志, 2017, 39(3): 166-171.
|